Teva Pharmaceuticals USA v. Sandoz Inc.

Appeal docketed. Received: 07/27/2012. [19777]Entry of Appearance due 08/16/2012. Certificate of Interest is due on 08/16/2012. Docketing Statement due 08/16/2012. Appellant/Petitioner's brief due 10/01/2012. [SJ] [Entered: 08/02/2012 03:22 PM]

2012-08-02

1

View

Note to file: 12-1568, 12-1569, 12-1570 (appeals started 08/02/2012) are consolidated with 12-1567. [19786] [SJ] [Entered: 08/02/2012 03:59 PM]

2012-08-02

1

View

Amended Certified list from the United States District Court for the Southern District of New York (New York City). Service: 07/27/2012 by email. [19789] [SJ] [Entered: 08/02/2012 04:01 PM]

2012-08-02

1

View

Notice from the United States District Court for the Southern District of New York (New York City) - Appeal Information Sheet. [19790] [SJ] [Entered: 08/02/2012 04:03 PM]

2012-08-02

1

View

Entry of appearance for Deanne E. Maynard as principal counsel for Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Service: 08/16/2012 by email. [21550] [Deanne Maynard] [Entered: 08/16/2012 02:05 PM]

2012-08-16

1

View

Entry of appearance for David C. Doyle as of counsel for Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Service: 08/16/2012 by email. [21553] [David Doyle] [Entered: 08/16/2012 02:10 PM]

2012-08-16

1

View

Entry of appearance for Anders T. Aannestad as of counsel for Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Service: 08/16/2012 by email. [21554] [Anders Aannestad] [Entered: 08/16/2012 02:13 PM]

2012-08-16

1

View

Entry of appearance for Elizabeth J. Holland as principal counsel for Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd.. Service: 08/16/2012 by US mail, email. [21561] [Elizabeth Holland] [Entered: 08/16/2012 02:34 PM]

2012-08-16

1

View

Entry of appearance for Marc A. Hearron as of counsel for Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Service: 08/16/2012 by email. [21563] [Marc Hearron] [Entered: 08/16/2012 02:38 PM]

2012-08-16

1

View

Entry of appearance for William G. James, II as of counsel for Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd.. Service: 08/16/2012 by US mail, email. [21566] [William James] [Entered: 08/16/2012 02:42 PM]

2012-08-16

1

View

Entry of appearance for Brian M. Kramer as of counsel for Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Service: 08/16/2012 by email. [21569] [Brian Kramer] [Entered: 08/16/2012 02:47 PM]

2012-08-16

1

View

Docketing Statement for the Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd.. Service: 08/16/2012 by US mail, email. [21571] [William James] [Entered: 08/16/2012 02:50 PM]

2012-08-16

1

View

Certificate of Interest for the Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Service: 08/16/2012 by email. [21573] [Deanne Maynard] [Entered: 08/16/2012 02:54 PM]

2012-08-16

1

View

Certificate of Interest for the Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd.. Service: 08/16/2012 by US mail, email. [21574] [William James] [Entered: 08/16/2012 02:55 PM]

2012-08-16

1

View

Docketing Statement for the Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Service: 08/16/2012 by email. [21575] [Deanne Maynard] [Entered: 08/16/2012 02:56 PM]

2012-08-16

1

View

Entry of appearance for Henry C. Dinger as of counsel for Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 08/16/2012 by US mail, email. [21607] [Henry Dinger] [Entered: 08/16/2012 04:41 PM]

2012-08-16

1

View

Entry of appearance for David M. Hashmall as of counsel for Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 08/16/2012 by US mail, email. [21615] [David Hashmall] [Entered: 08/16/2012 04:53 PM]

2012-08-16

1

View

Entry of appearance for Daryl L. Wiesen as of counsel for Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 08/16/2012 by US mail, email. [21619] [Daryl Wiesen] [Entered: 08/16/2012 05:08 PM]

2012-08-16

1

View

Entry of appearance for Nicholas K. Mitrokostas as of counsel for Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 08/16/2012 by US mail, email. [21623] [Nicholas Mitrokostas] [Entered: 08/16/2012 05:32 PM]

2012-08-16

1

View

Entry of appearance for John T. Bennett as of counsel for Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 08/16/2012 by email. [21628] [John Bennett] [Entered: 08/16/2012 05:52 PM]

2012-08-16

1

View

Entry of appearance for Shannon M. Bloodworth as principal counsel for Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 08/16/2012 by US mail. [21649] This document has been rejected. See Doc No. [27] [EO] [Entered: 08/17/2012 08:48 AM]

2012-08-17

1

View

Entry of appearance for Brandon M. White as of counsel for Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 08/16/2012 by US mail. [21650] This document has been rejected. See Doc No. [27] [EO] [Entered: 08/17/2012 08:50 AM]

2012-08-17

1

View

Entry of appearance for David L. Anstaett as of counsel for Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 08/16/2012 by US mail. [21651] This document has been rejected. See Doc No. [27] [EO] [Entered: 08/17/2012 08:51 AM]

2012-08-17

1

View

Certificate of Interest for the Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 08/16/2012 by. [21652] This document has been rejected. See Doc No. [27] [EO] [Entered: 08/17/2012 08:52 AM]

2012-08-17

1

View

Docketing Statement for the Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 08/16/2012 by US mail. [21653] This document has been rejected. See Doc No. [27] [EO] [Entered: 08/17/2012 08:53 AM]

2012-08-17

1

View

Transcript Purchase Order Form for the Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd. indicating that a transcript is already on file. Service: 08/16/2012 by US mail. [21654] This document has been rejected. See Doc No. [27] [EO] [Entered: 08/17/2012 08:55 AM]

2012-08-17

1

View

Notice of Rejection to Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd., the following document(s) cannot be filed: [21] attorney entry of appearance, [22] attorney entry of appearance, [23] attorney entry of appearance. Reason(s) The documents were not filed electronically., [24] certificate of interest. Reason(s) The document was not filed electronically. A completed certificate of Interest must be submitted in accordance with Fed. Cir. R. 47.4 by 08/31/2012., [25] docketing statement. Reason(s) The document was not filed electronically and the form is incomplete. Docketing Statement due 08/27/2012., [26] transcript purchase order form. Reason(s) The document was not filed electronically. Service: 08/17/2012 by clerk. [EO] [Entered: 08/17/2012 09:47 AM]

2012-08-17

1

View

Transcript Purchase Order Form for the Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc. indicating that a transcript is already on file. Service: 08/09/2012 by US mail. [21902] This document has been rejected. See Doc No. [29] [EO] [Entered: 08/20/2012 08:45 AM]

2012-08-20

1

View

Notice of Rejection to - Sandoz International GmbH and Appellant Momenta Pharmaceuticals Inc., the following document(s) cannot be filed: [28] transcript purchase order form. Reason(s) This document was not filed electronically. Service: 08/20/2012 by clerk. [EO] [Entered: 08/20/2012 08:47 AM]

2012-08-20

1

View

Duplicate Entry of appearance for Shannon M. Bloodworth as principal counsel for Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 08/20/2012 by email. [22088] This document has been rejected. See Doc No. [35] [Shannon Bloodworth] [Entered: 08/20/2012 08:27 PM]

2012-08-20

1

View

Duplicate Entry of appearance for David L. Anstaett as of counsel for Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 08/20/2012 by email. [22089] This document has been rejected. See Doc No. [35] [Shannon Bloodworth] [Entered: 08/20/2012 08:28 PM]

2012-08-20

1

View

Duplicate Entry of appearance for Brandon M. White as of counsel for Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 08/20/2012 by email. [22090] This document has been rejected. See Doc No. [35] [Shannon Bloodworth] [Entered: 08/20/2012 08:30 PM]

2012-08-20

1

View

Certificate of Interest for the Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 08/20/2012 by email. [22091] This document has been rejected. See Doc No. [35] [Shannon Bloodworth] [Entered: 08/20/2012 08:42 PM]

2012-08-20

1

View

Corrected Docketing Statement for the Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 08/20/2012 by email. [22092] This document has been rejected. See Doc No. [35] [Shannon Bloodworth] [Entered: 08/20/2012 08:43 PM]

2012-08-20

1

View

Notice of Rejection to Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd., the following document(s) cannot be filed: [30] attorney entry of appearance, [31] attorney entry of appearance, [32] attorney entry of appearance. Reason(s) The document is not text-searchable., [33] certificate of interest. Reason(s) The document is not text-searchable. A completed certificate of Interest must be submitted in accordance with Fed. Cir. R. 47.4 by 09/04/2012., [34] docketing statement. Reason(s) The document is not text-searchable. Docketing Statement due 08/31/2012. Service: 08/21/2012 by clerk. [EO] [Entered: 08/21/2012 11:15 AM]

2012-08-21

1

View

Entry of appearance for Shannon M. Bloodworth as principal counsel for Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 08/21/2012 by email. [22259] [Shannon Bloodworth] [Entered: 08/21/2012 06:17 PM]

2012-08-21

1

View

Entry of appearance for David L. Anstaett as of counsel for Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 08/21/2012 by email. [22260] [Shannon Bloodworth] [Entered: 08/21/2012 06:18 PM]

2012-08-21

1

View

Entry of appearance for Brandon M. White as of counsel for Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 08/21/2012 by email. [22261] [Shannon Bloodworth] [Entered: 08/21/2012 06:18 PM]

2012-08-21

1

View

Certificate of Interest for the Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 08/21/2012 by email. [22262] [Shannon Bloodworth] [Entered: 08/21/2012 06:26 PM]

2012-08-21

1

View

Docketing Statement for the Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 08/21/2012 by email. [22263] [Shannon Bloodworth] [Entered: 08/21/2012 06:26 PM]

2012-08-21

1

View

Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 09/17/2012 by email. [25597] [Shannon Bloodworth] [Entered: 09/17/2012 04:44 PM]

2012-09-17

1

View

Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd.. Service: 09/17/2012 by email. [25616] [William James] [Entered: 09/17/2012 05:46 PM]

2012-09-17

1

View

Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Service: 09/17/2012 by email. [25617] [Deanne Maynard] [Entered: 09/17/2012 05:48 PM]

2012-09-17

1

View

Entry of appearance for Adam A. Eltoukhy as of counsel for Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Service: 09/19/2012 by email. [25870] [Adam Eltoukhy] [Entered: 09/19/2012 12:18 PM]

2012-09-19

1

View

Entry of appearance for Brian R. Matsui as of counsel for Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Service: 09/19/2012 by email. [25872] [Brian Matsui] [Entered: 09/19/2012 12:22 PM]

2012-09-19

1

View

MOTION of Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc. to extend the time to 10/11/2012 to file the appellant/petitioner's principal brief. Response/Opposition due 10/09/2012. [Consent: unopposed]. Service: 09/24/2012 by email. [26619] [Deanne Maynard] [Entered: 09/24/2012 06:42 PM]

2012-09-24

1

View

MOTION of Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd. to extend the time to 10/11/2012 to file the appellant/petitioner's principal brief. Response/Opposition due 10/09/2012. [Consent: unopposed]. Service: 09/24/2012 by email. [26620] [Shannon Bloodworth] [Entered: 09/24/2012 06:58 PM]

2012-09-24

1

View

ORDER granting motion to extend time to file appellant/petitioner principal brief [46] filed by Appellants Sandoz, Inc. and Momenta Pharmaceuticals Inc. Brief due 10/11/2012.. Service: 09/25/2012 by clerk. [26722] [LAJ] [Entered: 09/25/2012 01:24 PM]

2012-09-25

1

View

ORDER granting motion to extend time to file the principal brief [47] filed by Appellants Mylan Pharmaceuticals Inc., Mylan Inc. and Natco Pharma Ltd.. Service: 09/25/2012 by clerk. [26727] [LAJ] [Entered: 09/25/2012 01:30 PM]

2012-09-25

1

View

CONFIDENTIAL BRIEF TENDERED from Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Title: Confidential Brief for Defendants-Appellants Sandoz Inc. and Momenta Pharmaceuticals Inc.. Service: 10/11/2012 by email. [29460] [Deanne Maynard] [Entered: 10/11/2012 06:51 PM]

2012-10-11

1

View

BRIEF TENDERED from Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Title: Non-Confidential Brief for Defendants-Appellants Sandoz Inc. and Momenta Pharmaceuticals Inc.. Service: 10/11/2012 by email. [29463] [Deanne Maynard] [Entered: 10/11/2012 06:59 PM]

2012-10-11

1

View

CONFIDENTIAL BRIEF TENDERED from Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Title: Confidential Opening Brief of Defendants-Appellants Mylan Pharmaceuticals Inc., Mylan Inc. and Natco Pharma Ltd.. Service: 10/11/2012 by email. [29467] [Shannon Bloodworth] [Entered: 10/11/2012 10:38 PM]

2012-10-11

1

View

BRIEF TENDERED from Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Title: Public Opening Brief of Defendants-Appellants Mylan Pharmaceuticals Inc., Mylan Inc. and Natco Pharma Ltd.. Service: 10/11/2012 by email. [29468] This brief has been rejected. See Doc. No. [55] [Shannon Bloodworth] [Entered: 10/11/2012 10:40 PM]

2012-10-11

1

View

NOTICE OF REJECTION: The brief of Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd., Brief of Defendants-Appellants Mylan Pharmaceuticals, Inc., Mylan Inc. and Natco Pharma Ltd. [53], [52], is not in compliance with the rules of this court and is therefore rejected for filing. Brief due 10/25/2012. Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd. brief due 11/29/2012. [29851] [CC] [Entered: 10/15/2012 02:14 PM]

2012-10-11

1

View

NOTICE OF REJECTION: The brief of Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc., Brief for Defendants-Appellants Sandoz Inc. and Momenta Pharmaceuitcals Inc. [51], [50], is not in compliance with the rules of this court and is therefore rejected for filing. Brief due 10/25/2012. [29857] [CC] [Entered: 10/15/2012 02:37 PM]

2012-10-11

1

View

BRIEF TENDERED from Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Title: Non-Confidential Brief for Defendants-Appellants Sandoz Inc. and Momenta Pharmaceuticals Inc.. Service: 10/11/2012 by email. [29463]

2012-10-11

1

View

BRIEF TENDERED from Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Title: Non-Confidential Brief for Defendants-Appellants Sandoz Inc. and Momenta Pharmaceuticals Inc.. Service: 10/11/2012 by email. [29463]

2012-10-11

1

View

BRIEF TENDERED from Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Title: Public Opening Brief of Defendants-Appellants Mylan Pharmaceuticals Inc., Mylan Inc. and Natco Pharma Ltd.. Service: 10/11/2012 by email. [29468] This brief has been rejected. See Doc. No. [55]

2012-10-11

1

View

BRIEF TENDERED from Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Title: Public Opening Brief of Defendants-Appellants Mylan Pharmaceuticals Inc., Mylan Inc. and Natco Pharma Ltd.. Service: 10/11/2012 by email. [29468] This brief has been rejected. See Doc. No. [55]

2012-10-11

1

View

Entry of appearance for David E. Jones as of counsel for Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 10/12/2012 by email. [29662] [Shannon Bloodworth] [Entered: 10/12/2012 04:22 PM]

2012-10-12

1

View

CONFIDENTIAL BRIEF TENDERED from Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Title: Corrected Confidential Brief for Defendants-Appellants Sandoz Inc. and Momenta Pharmaceuticals Inc.. Service: 10/16/2012 by email. [30113] [Deanne Maynard] [Entered: 10/16/2012 01:49 PM]

2012-10-16

1

View

BRIEF TENDERED from Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Title: Corrected Non-Confidential Brief for Defendants-Appellants Sandoz Inc. and Momenta Pharmaceuticals Inc.. Service: 10/16/2012 by email. [30115] [Deanne Maynard] [Entered: 10/16/2012 01:54 PM]

2012-10-16

1

View

BRIEF TENDERED from Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Title: Corrected Nonconfidential Brief of Defendants-Appellants Mylan Pharmaceuticals Inc., Mylan Inc. and Natco Pharma Ltd.. Service: 10/16/2012 by email. [30176] [Shannon Bloodworth] [Entered: 10/16/2012 06:16 PM]

2012-10-16

1

View

CONFIDENTIAL BRIEF TENDERED from Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Title: Corrected Confidential Brief of Defendants-Appellants Mylan Pharmaceuticals Inc., Mylan Inc. and Natco Pharma Ltd.. Service: 10/16/2012 by email. [30177] [Shannon Bloodworth] [Entered: 10/16/2012 06:23 PM]

2012-10-16

1

View

BRIEF FILED for Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc. [58], [57]. Title: Corrected Brief for Defendants-Appellants Sandoz Inc. and Momenta Pharmaceuiticals Inc., [Confidential and Non-Confidential versions]. Number of Pages: 67. Service: 10/16/2012 by email.. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 10/22/2012. [30241] [CC] [Entered: 10/17/2012 11:36 AM]

2012-10-16

1

View

BRIEF FILED for Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd. [60], [59]. Title: Corrected Opening Brief of Defendants-Appellants Mylan Inc., et al., [Confidential and Non-Confidential versions]. Number of Pages: 55. Service: 10/16/2012 by email.. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 10/22/2012. [30261] [CC] [Entered: 10/17/2012 12:02 PM]

2012-10-16

1

View

BRIEF FILED for Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd. [60], [59]. Title: Corrected Opening Brief of Defendants-Appellants Mylan Inc., et al., [Confidential and Non-Confidential versions]. Number of Pages: 55. Service: 10/16/2012 by email.. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 10/22/2012. [30261] [CC] [Entered: 10/17/2012 12:02 PM]

2012-10-16

2

View

6 paper copies of the 1st brief Brief [61] received from Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. [31699] [CC] [Entered: 10/26/2012 09:38 AM]

2012-10-22

1

View

6 paper copies of the 1st brief Brief [62] received from Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. [31700] [CC] [Entered: 10/26/2012 09:39 AM]

2012-10-22

1

View

MOTION of Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd. to extend the time to 12/21/2012 to file the appellee/respondent/cross-appellant's principal brief. Response/Opposition due 11/29/2012. [Consent: unopposed]. Service: 11/13/2012 by email. [34056] [Elizabeth Holland] [Entered: 11/13/2012 05:51 PM]

2012-11-13

1

View

MOTION of Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd. Leave to FiIe Appellate Brief in Excess of Word Limit in Response to Appellants' Multiple Merits Submissions. Response/Opposition due 11/29/2012. [Consent: not addressed]. Service: 11/13/2012 by email. [34059] [Elizabeth Holland] [Entered: 11/13/2012 06:03 PM]

2012-11-13

1

Download

MOTION of Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd. to extend the time to 12/21/2012 to file the appellee/respondent/cross-appellant's principal brief. Response/Opposition due 12/13/2012. [Consent: unopposed]. Service: 11/28/2012 by email. [35828] [William James] [Entered: 11/28/2012 10:41 AM]

2012-11-28

1

View

MOTION of Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc. to withdraw counsel Adam Eltoukhy. Response/Opposition due 12/26/2012. [Consent: unopposed]. Service: 12/10/2012 by email. [37807] [Adam Eltoukhy] [Entered: 12/10/2012 02:35 PM]

2012-12-10

1

Download

Entry of appearance for John C. Englander as of counsel for Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 12/20/2012 by email, US mail. [39912] [John Englander] [Entered: 12/20/2012 05:07 PM]

2012-12-20

1

View

BRIEF TENDERED from Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd.. Title: BRIEF OF PLAINTIFFS-APPELLEES. Service: 12/21/2012 by US mail, email. [40168] [Elizabeth Holland] [Entered: 12/21/2012 09:17 PM]

2012-12-21

1

View

BRIEF FILED for Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd. [70]. Title: Brief of Plaintiffs-Appellees, [Non-Confidential version only]. Number of Pages: 68. Service: 12/21/2012 by email.. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 01/02/2013. Appellants Momenta Pharmaceuticals Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Natco Pharma Ltd. and Sandoz, Inc. reply brief due 01/07/2013. [40568] [CC] [Entered: 12/28/2012 10:09 AM]

2012-12-21

1

View

MOTION of Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc. to extend the time to 01/25/2013 to file the reply brief. Response/Opposition due 01/10/2013. [Consent: unopposed]. Service: 12/27/2012 by email. [40381] [Deanne Maynard] [Entered: 12/27/2012 10:36 AM]

2012-12-27

1

View

MOTION of Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd. to extend the time to 01/25/2013 to file the reply brief. Response/Opposition due 01/10/2013. [Consent: unopposed]. Service: 12/27/2012 by email. [40415] [Shannon Bloodworth] [Entered: 12/27/2012 12:07 PM]

2012-12-27

1

View

ORDER granting motion to extend time to file reply brief [72] filed by Appellants Mylan Pharmaceuticals Inc., Mylan Inc. and Natco Pharma Ltd., granting motion to extend time to file reply brief [71] filed by Appellants Sandoz, Inc. and Momenta Pharmaceuticals Inc. reply brief is due 01/25/2013.. Service: 12/28/2012 by clerk. [40729] [LP] [Entered: 12/28/2012 03:08 PM]

2012-12-28

1

View

6 paper copies of the 2nd brief Brief [73] received from Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd.. [40918] [VDW] [Entered: 01/02/2013 02:23 PM]

2013-01-02

1

View

ORDER granting motions [65], [67] to extend time to file appellees' response brief filed by Appellees Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co., Ltd. and Teva Neuroscience, Inc. The briefing schedule is stayed pending disposition of Teva's motion for leave to file an extended brief. Service: 01/10/2013 by clerk. [42412] [LMS] [Entered: 01/10/2013 01:59 PM]

2013-01-10

1

View

ORDER granting motion [68] to withdraw Adam Eltoukhy as counsel for Sandoz, Inc. and Momenta Pharmaceuticals Inc. Service: 01/10/2013 by clerk. [42417] [LMS] [Entered: 01/10/2013 02:05 PM]

2013-01-10

1

View

ORDER filed granting-in-part motion for leave to file an extended response brief not to exceed 26,000 words [66] filed by Appellees Teva Pharmaceutical Industries, Ltd., et al. Teva's response brief is due within 14 days of the date of this order and may not exceed 21, 000 words. Service: 02/01/2013 by clerk. [47173] [LMS] [Entered: 02/01/2013 10:00 AM]

2013-02-01

1

View

BRIEF TENDERED from Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd.. Title: BRIEF OF PLAINTIFFS-APPELLEES. Service: 01/15/2013 by email, US mail. [51517] [Elizabeth Holland] [Entered: 02/15/2013 10:37 PM]

2013-02-15

1

View

BRIEF FILED for Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd. [79]. Title: Brief of Plaintiff - Appellees, [Non-Confidential version only]. Number of Pages: 86. Service: 02/15/2013 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format.. [51581] [VDW] [Entered: 02/19/2013 09:51 AM]

2013-02-15

1

View

6 paper copies of the 2nd brief Brief [80] received from Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd.. [52200] [VDW] [Entered: 02/20/2013 02:38 PM]

2013-02-20

1

View

BRIEF TENDERED from Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Title: Reply Brief for Defendants-Appellants Sandoz Inc. and Momenta Pharmaceuticals Inc.. Service: 03/04/2013 by email. [55578] [Deanne Maynard] [Entered: 03/04/2013 06:45 PM]

2013-03-04

1

View

BRIEF TENDERED from Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Title: Reply Brief of Defendants-Appellants Mylan Pharmaceuticals Inc., Mylan Inc. and Natco Pharma Ltd.. Service: 03/04/2013 by email. [55579] [Shannon Bloodworth] [Entered: 03/04/2013 07:04 PM]

2013-03-04

1

View

MOTION of Appellants Momenta Pharmaceuticals Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Natco Pharma Ltd. and Sandoz, Inc. to extend the time to 03/15/2013 to file the appendix. Response/Opposition is due 03/18/2013 [Consent: unopposed]. Service: 03/04/2013 by email. [55584] [Deanne Maynard] [Entered: 03/04/2013 07:13 PM]

2013-03-04

1

View

BRIEF FILED for Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc. [82]. Title: Reply Brief for Defendants-Appellants Sandoz Inc. and Momenta Pharmaceuticals Inc., [Non-Confidential version only]. Number of Pages: 41. Service: 03/04/2013 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 03/12/2013. [56278] [VDW] [Entered: 03/07/2013 08:42 AM]

2013-03-04

1

View

BRIEF FILED for Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd. [83]. Title: Reply Brief of Defendants-Appellants Mylan Pharmaceuticals Inc., Mylan Inc. and Natco Pharma Ltd., [Non-Confidential version only]. Number of Pages: 30. Service: 03/04/2013 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 03/12/2013. [56282] [VDW] [Entered: 03/07/2013 08:47 AM]

2013-03-04

1

View

ORDER granting motion to extend time to file appendix [84] filed by Appellants Mylan Pharmaceuticals Inc., Mylan Inc., Sandoz, Inc., Momenta Pharmaceuticals Inc. and Natco Pharma Ltd. Appendix due 03/15/2013.. Service: 03/05/2013 by clerk. [55717] [LP] [Entered: 03/05/2013 11:24 AM]

2013-03-05

1

View

6 paper copies of the 3rd brief Brief [86] received from Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. [56869] [VDW] [Entered: 03/08/2013 11:01 AM]

2013-03-08

1

View

6 paper copies of the 3rd brief Brief [87] received from Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. [57116] [VDW] [Entered: 03/08/2013 03:58 PM]

2013-03-08

1

View

APPENDIX TENDERED from Appellants Momenta Pharmaceuticals Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Natco Pharma Ltd., Sandoz, Inc. and Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd.. Title: NON-CONFIDENTIAL JOINT APPENDIX (VOLUME 1 AND 2). Service: 03/13/2013 by email, US mail. [58485] [Deanne Maynard] [Entered: 03/13/2013 07:18 PM]

2013-03-13

1

View

APPENDIX TENDERED from Appellants Momenta Pharmaceuticals Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Natco Pharma Ltd., Sandoz, Inc. and Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd.. Title: NON-CONFIDENTIAL JOINT APPENDIX VOLUME 3. Service: 03/13/2013 by email, US mail. [58486] [Deanne Maynard] [Entered: 03/13/2013 07:19 PM]

2013-03-13

1

View

APPENDIX TENDERED from Appellants Momenta Pharmaceuticals Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Natco Pharma Ltd., Sandoz, Inc. and Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd.. Title: NON-CONFIDENTIAL JOINT APPENDIX VOLUME 4 (PARTS 1, 2 AND 3). Service: 03/13/2013 by email, US mail. [58487] [Deanne Maynard] [Entered: 03/13/2013 07:21 PM]

2013-03-13

1

View

APPENDIX TENDERED from Appellants Momenta Pharmaceuticals Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Natco Pharma Ltd., Sandoz, Inc. and Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd.. Title: NON-CONFIDENTIAL JOINT APPENDIX VOLUME 4 (PARTS 4 AND 5). Service: 03/13/2013 by email, US mail. [58488] [Deanne Maynard] [Entered: 03/13/2013 07:22 PM]

2013-03-13

1

View

APPENDIX TENDERED from Appellants Momenta Pharmaceuticals Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Natco Pharma Ltd., Sandoz, Inc. and Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd.. Title: NON-CONFIDENTIAL JOINT APPENDIX VOLUME 5. Service: 03/13/2013 by email, US mail. [58489] [Deanne Maynard] [Entered: 03/13/2013 07:23 PM]

2013-03-13

1

View

CONFIDENTIAL APPENDIX TENDERED from Appellants Momenta Pharmaceuticals Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Natco Pharma Ltd., Sandoz, Inc. and Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd.. Title: CONFIDENTIAL JOINT APPENDIX VOLUME 1 AND 2. Service: 03/13/2013 by email, US mail. [58490] [Deanne Maynard] [Entered: 03/13/2013 07:25 PM]

2013-03-13

1

View

CONFIDENTIAL APPENDIX TENDERED from Appellants Momenta Pharmaceuticals Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Natco Pharma Ltd., Sandoz, Inc. and Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd.. Title: CONFIDENTIAL JOINT APPENDIX VOLUME 3. Service: 03/13/2013 by email, US mail. [58491] [Deanne Maynard] [Entered: 03/13/2013 07:27 PM]

2013-03-13

1

View

CONFIDENTIAL APPENDIX TENDERED from Appellants Momenta Pharmaceuticals Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Natco Pharma Ltd., Sandoz, Inc. and Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd.. Title: CONFIDENTIAL JOINT APPENDIX VOLUME 4 (PARTS 1, 2, 3 AND 4). Service: 03/13/2013 by email, US mail. [58492] [Deanne Maynard] [Entered: 03/13/2013 07:29 PM]

2013-03-13

1

View

CONFIDENTIAL APPENDIX TENDERED from Appellants Momenta Pharmaceuticals Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Natco Pharma Ltd., Sandoz, Inc. and Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd.. Title: CONFIDENTIAL JOINT APPENDIX VOLUME 4 (PARTS 5, 6 AND 7). Service: 03/13/2013 by email, US mail. [58493] [Deanne Maynard] [Entered: 03/13/2013 07:31 PM]

2013-03-13

1

View

CONFIDENTIAL APPENDIX TENDERED from Appellants Momenta Pharmaceuticals Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Natco Pharma Ltd., Sandoz, Inc. and Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd.. Title: CONFIDENTIAL JOINT APPENDIX VOLUME 5. Service: 03/13/2013 by email, US mail. [58494] [Deanne Maynard] [Entered: 03/13/2013 07:32 PM]

2013-03-13

1

View

Notice of paper filing of the NOTICE OF INTENT TO FILE SUPPLEMENTARY VIDEO RECORDING MEDIA APPENDIX ON DVD for Mr. Anders T. Aannestad for Appellants Sandoz, Inc. and Momenta Pharmaceuticals Inc., David L. Anstaett, Esq. for Appellants Mylan Pharmaceuticals Inc., Mylan Inc. and Natco Pharma Ltd., Mrs. Shannon Bloodworth for Appellants Mylan Pharmaceuticals Inc., Mylan Inc. and Natco Pharma Ltd., David Clarence Doyle for Appellants Sandoz, Inc. and Momenta Pharmaceuticals Inc., Marc A. Hearron for Appellants Sandoz, Inc. and Momenta Pharmaceuticals Inc., David Jones for Appellants Mylan Pharmaceuticals Inc., Mylan Inc. and Natco Pharma Ltd., Brian M. Kramer for Appellants Sandoz, Inc. and Momenta Pharmaceuticals Inc., Brian Robert Matsui for Appellants Sandoz, Inc. and Momenta Pharmaceuticals Inc., Ms. Deanne Maynard for Appellants Sandoz, Inc. and Momenta Pharmaceuticals Inc., Mr. John Singleton Skilton for Appellants Mylan Pharmaceuticals Inc., Mylan Inc. and Natco Pharma Ltd., Brandon Michael White, Esq. for Appellants Mylan Pharmaceuticals Inc., Mylan Inc. and Natco Pharma Ltd., John T. Bennett for Appellees Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Teva Neuroscience, Inc., Henry C. Dinger for Appellees Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Teva Neuroscience, Inc., John C. Englander for Appellees Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Teva Neuroscience, Inc., David M. Hashmall for Appellees Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Teva Neuroscience, Inc., Elizabeth J. Holland for Appellees Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co., Ltd. and Teva Neuroscience, Inc., William G. James, II for Appellees Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co., Ltd. and Teva Neuroscience, Inc., Nicholas K. Mitrokostas for Appellees Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Teva Neuroscience, Inc. and Daryl L. Wiesen for Appellees Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Teva Neuroscience, Inc.. Service: 03/13/2013 by email, US mail. [58495] [Deanne Maynard] [Entered: 03/13/2013 07:34 PM]

2013-03-13

1

View

APPENDIX FILED for Momenta Pharmaceuticals Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Natco Pharma Ltd., Sandoz, Inc. and Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd. [99], [98], [97], [96], [95], [94], [93], [92], [91], [90]. Title: Joint Appendix, [Confidential and Non-Confidential versions]. Number of Pages: 300. Service: 03/13/2013 by email.. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 03/19/2013. [58714] [LAJ] [Entered: 03/14/2013 02:18 PM]

2013-03-13

1

View

6 paper copies of the confidential Brief [99] received from Appellants Momenta Pharmaceuticals Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Natco Pharma Ltd. and Sandoz, Inc.. [59083] [VDW] [Entered: 03/15/2013 02:37 PM]

2013-03-15

1

View

NOTICE OF CALENDARING issued. Panel: 1305C. Calendar date/location: Tuesday, 05/07/2013 Washington, D.C. Courtroom 201. Response to oral argument order due: 04/15/2013 [60553] [KSH] [Entered: 03/21/2013 09:59 AM]

2013-03-21

1

View

This entry was made in error and has been removed from the docket. NOTICE OF CALENDARING issued. Panel: -. Calendar date/location: Tuesday, 05/07/2013 Washington, D.C. Courtroom 201. Response to oral argument order due: 04/15/2013 [60555] Notice sent in error. Disregard this order; set in wrong appeal--[Edited 03/21/2013 by KSH] [KSH] [Entered: 03/21/2013 10:01 AM]

2013-03-21

1

View

Entry of appearance for Evan R. Chesler as of counsel for Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 04/03/2013 by email. [64425] [Evan Chesler] [Entered: 04/03/2013 07:31 PM]

2013-04-03

1

View

Certificate of Interest for the Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 04/03/2013 by email. [64426] [Evan Chesler] [Entered: 04/03/2013 07:32 PM]

2013-04-03

1

View

Response to oral argument order from the Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd. designating Evan R. Chesler as arguing attorney. Service: 04/04/2013 by email. [64610] [Evan Chesler] [Entered: 04/04/2013 12:39 PM]

2013-04-04

1

View

Response to oral argument order from the Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc. designating Deanne E. Maynard as arguing attorney. Service: 04/04/2013 by email. [64713] [Deanne Maynard] [Entered: 04/04/2013 02:27 PM]

2013-04-04

1

View

Response to oral argument order from the Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd. designating Elizabeth J. Holland as arguing attorney. Service: 04/12/2013 by email. [67822] [Elizabeth Holland] [Entered: 04/12/2013 04:35 PM]

2013-04-12

1

View

MOTION of Appellants Momenta Pharmaceuticals Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Natco Pharma Ltd. and Sandoz, Inc. for additional time at oral argument. Response/Opposition is due 05/02/2013 [Consent: unopposed]. Service: 04/17/2013 by email. [68884] [Deanne Maynard] [Entered: 04/17/2013 05:52 PM]

2013-04-17

1

View

ORDER filed granting motion to seek more time for argument [110] filed by Appellants Mylan Pharmaceuticals Inc., Mylan Inc., Sandoz, Inc., Momenta Pharmaceuticals Inc. and Natco Pharma Ltd.. The Appellants will share 20 minutes oral argument time to be divided as they choose. The Appellees also will have 20 minutes time at oral argument.. By: Merits Panel (Per Curiam). Service: 04/22/2013 by clerk. [69842] [KSH] [Entered: 04/22/2013 11:32 AM]

2013-04-22

1

View

MOTION of Appellants Momenta Pharmaceuticals Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Natco Pharma Ltd. and Sandoz, Inc. to correct the appendix Brief [101]. Response/Opposition is due 05/09/2013 [Consent: unopposed]. Service: 04/25/2013 by email. [71491] [Deanne Maynard] [Entered: 04/25/2013 03:12 PM]

2013-04-25

1

View

ORDER filed granting motion to correct the paper version of the Confidential Joint Appendix [112] filed by Appellants Mylan Pharmaceuticals Inc., Mylan Inc., Sandoz, Inc., Momenta Pharmaceuticals Inc. and Natco Pharma Ltd.. By: Merits Panel (Per Curiam). Service: 05/01/2013 by clerk. [73545] [KSH] [Entered: 05/01/2013 02:54 PM]

2013-05-01

1

View

Submitted after ORAL ARGUMENT by Evan Chesler for Mylan Pharmaceuticals Inc., Mylan Inc. and Natco Pharma Ltd., Ms. Deanne Maynard for Sandoz, Inc. and Momenta Pharmaceuticals Inc. and Elizabeth J. Holland for Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co., Ltd. and Teva Neuroscience, Inc.. Panel: Rader, Moore and Benson. [75097] [LP] [Entered: 05/07/2013 10:34 AM]

2013-05-07

1

View

OPINION and JUDGMENT filed. The judgment or decision is: Affirmed-in-Part, Reversed-in-Part and Remanded. (Precedential Opinion). (For the Court: Rader,Chief Judge; Moore,Circuit Judge and Benson,United States District Judge). [94366] [CS] [Entered: 07/26/2013 11:42 AM]

2013-07-26

2

Download

MOTION of Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd. to extend the time to file a Combined Petition for Panel Rehearing and Rehearing En Banc until 09/16/2013 [Consent: unopposed]. Service: 08/05/2013 by email. [96242] [Elizabeth Holland] [Entered: 08/05/2013 08:00 PM]

2013-08-05

1

View

ORDER filed granting motion to extend time until 9.16.13 to file petition for rehearing [116] filed by Appellees Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co., Ltd. and Teva Neuroscience, Inc. By: Merits Panel (Per Curiam). Service: 08/08/2013 by. [96913] [LB] [Entered: 08/08/2013 11:24 AM]

2013-08-08

1

View

Petition for en banc rehearing filed by Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd.. Service: 09/16/2013 by email. [103929]--[EDITED 09/17/2013 by the clerk AT--entry 118 is replaced by corrected petition filed in entry 119] [Elizabeth Holland] [Entered: 09/16/2013 04:27 PM]

2013-09-16

1

View

Corrected Petition for panel rehearing, for en banc rehearing filed by Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd.. Service: 09/16/2013 by email. [103958]--[Edited 09/17/2013 by AT to add "corrected" to docket text] [Elizabeth Holland] [Entered: 09/16/2013 05:54 PM]

2013-09-16

1

View

16 paper copies of the petition for panel rehearing [119], petition for en banc rehearing [119] received from Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd. [104585] [LB] [Entered: 09/18/2013 03:14 PM]

2013-09-18

1

View

ORDER filed denying [119] petition for panel rehearing filed by Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co., Ltd. and Teva Neuroscience, Inc.; denying [119] petition for en banc rehearing filed by Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co., Ltd. and Teva Neuroscience, Inc. The mandate will issue on 10/25/2013. By: En Banc (Per Curiam). Service: 10/18/2013 by clerk. [111261] [JXB] [Entered: 10/18/2013 12:39 PM]

2013-10-18

1

View

MOTION of Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd. to clarify [115] Opinion and Judgment filed 7/26/2013. Response/Opposition is due 11/07/2013 [Consent: opposed]. Service: 10/24/2013 by email. [112760] [Elizabeth Holland] [Entered: 10/24/2013 04:39 PM]

2013-10-24

1

View

MOTION of Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd. to stay execution of the mandate until pending filing of the Petition for Certiorari [Consent: opposed]. Service: 10/24/2013 by email. [112764] [Elizabeth Holland] [Entered: 10/24/2013 04:45 PM]

2013-10-24

1

View

ORDER filed denying [122] motion to clarify filed by Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co., Ltd. and Teva Neuroscience, Inc.; denying [123] motion to stay mandate filed by Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co., Ltd. and Teva Neuroscience, Inc.. By: Merits Panel (Per Curiam). Service: 11/01/2013 by clerk. [114260] [JXB] [Entered: 11/01/2013 10:48 AM]

2013-11-01

1

View

Mandate issued to the United States District Court for the Southern District of New York. Service: 11/01/2013 by clerk. [114268] [12-1567, 12-1568, 12-1569, 12-1570] [JXB] [Entered: 11/01/2013 10:58 AM]

2013-11-01

1

View

Petition for writ of Certiorari filed on 01/16/2014 in the Supreme Court of the United States. Supreme Court #: 13-854, Teva Pharmaceuticals USA, Inc. v. Inc. Sandoz, Inc. --[Edited 06/09/2014 by clerk to correct error in Supreme Court docket number] [CS] [Entered: 01/24/2014 11:33 AM]

2014-01-17

1

View

This entry was made in error and has been removed from the docket. The petition for writ of certiorari, [12-1567], filed on 01/16/2014, was Granted on. [149378] [CS] [Entered: 04/21/2014 02:16 PM]

2014-04-21

1

View

The petition for writ of certiorari, [13-854], filed on 01/16/2014, was Granted on 03/31/2014. [150118] [CS] [Entered: 04/23/2014 04:28 PM]

2014-04-23

1

View

Letter from the Supreme Court of the United States requesting the entire record and briefs. [166510] [CS] [Entered: 07/10/2014 01:11 PM]

2014-07-09

1

View

This entry was made in error and has been removed from the docket. Letter from the Supreme Court of the United States requesting the entire record and briefs. [166437] [CS] [Entered: 07/10/2014 10:56 AM]

2014-07-10

1

View

Record transmitted to the Supreme Court on 07/15/2014. [CS] [Entered: 07/15/2014 03:11 PM]

2014-07-15

1

View

Notice from the Supreme Court of the United States Notice that the opinion of the court was issued. [218300] [SW] [Entered: 02/19/2015 10:03 AM]

2015-01-20

1

View

Certified judgment of the Supreme Court of the United States issued on 02/18/2015 for 13-854. [218297] [SW] [Entered: 02/19/2015 09:59 AM]

2015-02-19

1

View

SUPREME COURT OF THE UNITED STATES opinion filed on 01/20/2015 in case 13-854. Ruling of the Supreme Court: Vacated and Remanded. [218303] [SW] [Entered: 02/19/2015 10:06 AM]

2015-02-19

1

View

MOTION of Appellants Momenta Pharmaceuticals Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Natco Pharma Limited, Sandoz, Inc. and Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd. to set briefing schedule. Response/Opposition is due 03/05/2015 [Consent: unopposed]. Service: 02/20/2015 by email. [218576] [Deanne Maynard] [Entered: 02/20/2015 08:02 AM]

2015-02-20

1

View

TENDERED from Appellants Momenta Pharmaceuticals Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Natco Pharma Limited and Sandoz, Inc.. Title: SUPPLEMENTAL BRIEF/APPENDIX. Service: 02/20/2015 by email. [218577] [Deanne Maynard] [Entered: 02/20/2015 08:06 AM]

2015-02-20

1

View

ORDER filed requesting letter briefs from the parties. Letter briefs are due within 10 days of this order. By: (Per Curiam). Service as of this date by Clerk of Court. [218903] [VDW] [Entered: 02/20/2015 04:27 PM]

2015-02-20

1

View

ORDER filed denying [135] motion to set briefing schedule filed by Mylan Pharmaceuticals Inc., Mylan Inc., Sandoz, Inc., Momenta Pharmaceuticals Inc., Natco Pharma Limited and Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co., Ltd. and Teva Neuroscience, Inc.. By:(Per Curiam). Service as of this date by Clerk of Court. [218904] [VDW] [Entered: 02/20/2015 04:30 PM]

2015-02-20

1

View

TENDERED from Appellants Momenta Pharmaceuticals Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Natco Pharma Limited and Sandoz, Inc.. Title: SUPPLEMENTAL BRIEF/APPENDIX. Service: 02/20/2015 by email. [218577]

2015-02-20

1

View

TENDERED from Appellants Momenta Pharmaceuticals Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Natco Pharma Limited and Sandoz, Inc.. Title: SUPPLEMENTAL BRIEF/APPENDIX. Service: 02/20/2015 by email. [218577]

2015-02-20

1

View

Entry of appearance for William M. Jay as of counsel for Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd.. Service: 02/25/2015 by email. [220016] [William Jay] [Entered: 02/25/2015 04:17 PM]

2015-02-25

1

View

TENDERED from Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd.. Title: LETTER BRIEF. Service: 03/02/2015 by email. [221080] [William Jay] [Entered: 03/02/2015 11:45 PM]

2015-03-02

1

Download

TENDERED from Appellants Momenta Pharmaceuticals Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Natco Pharma Limited and Sandoz, Inc.. Title: LETTER BRIEF. Service: 03/02/2015 by email. [221081] [Deanne Maynard] [Entered: 03/02/2015 11:46 PM]

2015-03-02

1

Download

BRIEF FILED (LETTER) of [140] Number of Pages: 15. Service: 03/03/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. [221228] [SW] [Entered: 03/03/2015 01:12 PM]

2015-03-03

1

View

BRIEF FILED (LETTER) of [141] Number of Pages: 15. Service: 03/02/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. [221229] [SW] [Entered: 03/03/2015 01:14 PM]

2015-03-03

1

View

MOTION of Appellants Momenta Pharmaceuticals Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Natco Pharma Limited, Sandoz, Inc. and Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd. to file a supplemental appendix. Response/Opposition is due 03/16/2015 [Consent: unopposed]. Service: 03/03/2015 by email. [221344] [Elizabeth Holland] [Entered: 03/03/2015 04:27 PM]

2015-03-03

1

View

TENDERED from Appellants Momenta Pharmaceuticals Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Natco Pharma Limited, Sandoz, Inc. and Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd.. Title: SUPPLEMENTAL BRIEF/APPENDIX. Service: 03/03/2015 by email. [221346] [Elizabeth Holland] [Entered: 03/03/2015 04:29 PM]

2015-03-03

1

View

TENDERED from Appellants Momenta Pharmaceuticals Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Natco Pharma Limited, Sandoz, Inc. and Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd.. Title: SUPPLEMENTAL BRIEF/APPENDIX. Service: 03/03/2015 by email. [221346]

2015-03-03

1

View

6 paper copies of the letter Brief [143] received from Appellants Momenta Pharmaceuticals Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Natco Pharma Limited and Sandoz, Inc.. [222321] [SW] [Entered: 03/09/2015 08:44 AM]

2015-03-09

1

View

6 paper copies of the letter Brief [142] received from Appellees Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. [227050] [SW] [Entered: 03/25/2015 03:07 PM]

2015-03-25

1

View

Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Service: 04/16/2015 by email. [233412] [Deanne Maynard] [Entered: 04/16/2015 12:44 PM]

2015-04-16

1

View

ORDER filed granting motion to file supplemental appendix [144] filed by Appellants Mylan Pharmaceuticals Inc., Mylan Inc., Sandoz, Inc., Momenta Pharmaceuticals Inc., Natco Pharma Limited and Appellees Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co., Ltd. and Teva Neuroscience, Inc... By: Court (Per Curiam). Service as of this date by Clerk of Court. [249538] [JCS] [Entered: 06/18/2015 09:16 AM]

2015-06-18

1

View

APPENDIX FILED (SUPPLEMENTAL) for Momenta Pharmaceuticals Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Natco Pharma Limited, Sandoz, Inc. and Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd. [145]. Number of Pages: 22. Service: 03/03/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format.. [249541] [JCS] [Entered: 06/18/2015 09:23 AM]

2015-06-18

1

View

OPINION and JUDGMENT filed. The judgment or decision is: Affirmed-in-part, Reversed-in-part. (Precedential Opinion). (For the Court: Moore,Circuit Judge; Mayer,Circuit Judge and Wallach,Circuit Judge). Dissenting opinion filed by Circuit Judge Mayer. [249550] [12-1567, 12-1568, 12-1569, 12-1570] [JCS] [Entered: 06/18/2015 09:37 AM]

2015-06-18

1

Download

OPINION and JUDGMENT filed. The judgment or decision is: Affirmed-in-part, Reversed-in-part. (Precedential Opinion). (For the Court: Moore,Circuit Judge; Mayer,Circuit Judge and Wallach,Circuit Judge). Dissenting opinion filed by Circuit Judge Mayer. [249550] [12-1567, 12-1568, 12-1569, 12-1570] [JCS] [Entered: 06/18/2015 09:37 AM]

2015-06-18

2

View

OPINION and JUDGMENT filed. The judgment or decision is: Affirmed-in-part, Reversed-in-part. (Precedential Opinion). (For the Court: Moore,Circuit Judge; Mayer,Circuit Judge and Wallach,Circuit Judge). Dissenting opinion filed by Circuit Judge Mayer. [249550] [12-1567, 12-1568, 12-1569, 12-1570] [JCS] [Entered: 06/18/2015 09:37 AM]

2015-06-18

2

View

OPINION and JUDGMENT filed. The judgment or decision is: Affirmed-in-part, Reversed-in-part. (Precedential Opinion). (For the Court: Moore,Circuit Judge; Mayer,Circuit Judge and Wallach,Circuit Judge). Dissenting opinion filed by Circuit Judge Mayer. [249550] [12-1567, 12-1568, 12-1569, 12-1570] [JCS] [Entered: 06/18/2015 09:37 AM]

2015-06-18

2

View

Mandate issued to the United States District Court for the Southern District of New York. Service as of this date by Clerk of Court. [259522] [12-1567, 12-1568, 12-1569, 12-1570] [CAB] [Entered: 07/27/2015 10:01 AM]

2015-07-27

1

View

Overview

Parties

Defendant

SANDOZ INTERNATIONAL GMBH Follow

Represented By

NOVARTIS AG Follow

Represented By

Plaintiff - Appellee

YEDA RESEARCH AND DEVELOPMENT CO., LTD. Follow

Represented By

TEVA NEUROSCIENCE, INC. Follow

Represented By

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Follow

Represented By

TEVA PHARMACEUTICALS USA, INC. Follow

Represented By

Defendant - Appellant

NATCO PHARMA LIMITED Follow

Represented By

MYLAN PHARMACEUTICALS INC. Follow

Represented By

MYLAN INC. Follow

Represented By

MOMENTA PHARMACEUTICALS, INC. Follow

Represented By

SANDOZ INC. Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

Appeal docketed. Received: 07/27/2012. [19777]Entry of Appearance due 08/16/2012. Certificate of Interest is due on 08/16/2012. Docketing Statement due 08/16/2012. Appellant/Petitioner's brief due 10/01/2012. [SJ] [Entered: 08/02/2012 03:22 PM]

Note to file: 12-1568, 12-1569, 12-1570 (appeals started 08/02/2012) are consolidated with 12-1567. [19786] [SJ] [Entered: 08/02/2012 03:59 PM]

Amended Certified list from the United States District Court for the Southern District of New York (New York City). Service: 07/27/2012 by email. [19789] [SJ] [Entered: 08/02/2012 04:01 PM]

Notice from the United States District Court for the Southern District of New York (New York City) - Appeal Information Sheet. [19790] [SJ] [Entered: 08/02/2012 04:03 PM]

Entry of appearance for Deanne E. Maynard as principal counsel for Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Service: 08/16/2012 by email. [21550] [Deanne Maynard] [Entered: 08/16/2012 02:05 PM]

Entry of appearance for David C. Doyle as of counsel for Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Service: 08/16/2012 by email. [21553] [David Doyle] [Entered: 08/16/2012 02:10 PM]

Entry of appearance for Anders T. Aannestad as of counsel for Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Service: 08/16/2012 by email. [21554] [Anders Aannestad] [Entered: 08/16/2012 02:13 PM]

Entry of appearance for Marc A. Hearron as of counsel for Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Service: 08/16/2012 by email. [21563] [Marc Hearron] [Entered: 08/16/2012 02:38 PM]

Entry of appearance for Brian M. Kramer as of counsel for Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Service: 08/16/2012 by email. [21569] [Brian Kramer] [Entered: 08/16/2012 02:47 PM]

Docketing Statement for the Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd.. Service: 08/16/2012 by US mail, email. [21571] [William James] [Entered: 08/16/2012 02:50 PM]

Certificate of Interest for the Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Service: 08/16/2012 by email. [21573] [Deanne Maynard] [Entered: 08/16/2012 02:54 PM]

Certificate of Interest for the Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Yeda Research and Development Co., Ltd.. Service: 08/16/2012 by US mail, email. [21574] [William James] [Entered: 08/16/2012 02:55 PM]

Docketing Statement for the Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Service: 08/16/2012 by email. [21575] [Deanne Maynard] [Entered: 08/16/2012 02:56 PM]

Entry of appearance for Henry C. Dinger as of counsel for Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 08/16/2012 by US mail, email. [21607] [Henry Dinger] [Entered: 08/16/2012 04:41 PM]

Entry of appearance for David M. Hashmall as of counsel for Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 08/16/2012 by US mail, email. [21615] [David Hashmall] [Entered: 08/16/2012 04:53 PM]

Entry of appearance for Daryl L. Wiesen as of counsel for Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 08/16/2012 by US mail, email. [21619] [Daryl Wiesen] [Entered: 08/16/2012 05:08 PM]

Entry of appearance for Nicholas K. Mitrokostas as of counsel for Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 08/16/2012 by US mail, email. [21623] [Nicholas Mitrokostas] [Entered: 08/16/2012 05:32 PM]

Entry of appearance for John T. Bennett as of counsel for Appellees Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 08/16/2012 by email. [21628] [John Bennett] [Entered: 08/16/2012 05:52 PM]

Entry of appearance for Shannon M. Bloodworth as principal counsel for Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 08/16/2012 by US mail. [21649] This document has been rejected. See Doc No. [27] [EO] [Entered: 08/17/2012 08:48 AM]

Entry of appearance for Brandon M. White as of counsel for Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 08/16/2012 by US mail. [21650] This document has been rejected. See Doc No. [27] [EO] [Entered: 08/17/2012 08:50 AM]

Entry of appearance for David L. Anstaett as of counsel for Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 08/16/2012 by US mail. [21651] This document has been rejected. See Doc No. [27] [EO] [Entered: 08/17/2012 08:51 AM]

Certificate of Interest for the Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 08/16/2012 by. [21652] This document has been rejected. See Doc No. [27] [EO] [Entered: 08/17/2012 08:52 AM]

Docketing Statement for the Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 08/16/2012 by US mail. [21653] This document has been rejected. See Doc No. [27] [EO] [Entered: 08/17/2012 08:53 AM]

Transcript Purchase Order Form for the Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd. indicating that a transcript is already on file. Service: 08/16/2012 by US mail. [21654] This document has been rejected. See Doc No. [27] [EO] [Entered: 08/17/2012 08:55 AM]

Transcript Purchase Order Form for the Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc. indicating that a transcript is already on file. Service: 08/09/2012 by US mail. [21902] This document has been rejected. See Doc No. [29] [EO] [Entered: 08/20/2012 08:45 AM]

Notice of Rejection to - Sandoz International GmbH and Appellant Momenta Pharmaceuticals Inc., the following document(s) cannot be filed: [28] transcript purchase order form. Reason(s) This document was not filed electronically. Service: 08/20/2012 by clerk. [EO] [Entered: 08/20/2012 08:47 AM]

Duplicate Entry of appearance for Shannon M. Bloodworth as principal counsel for Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 08/20/2012 by email. [22088] This document has been rejected. See Doc No. [35] [Shannon Bloodworth] [Entered: 08/20/2012 08:27 PM]

Duplicate Entry of appearance for David L. Anstaett as of counsel for Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 08/20/2012 by email. [22089] This document has been rejected. See Doc No. [35] [Shannon Bloodworth] [Entered: 08/20/2012 08:28 PM]

Duplicate Entry of appearance for Brandon M. White as of counsel for Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 08/20/2012 by email. [22090] This document has been rejected. See Doc No. [35] [Shannon Bloodworth] [Entered: 08/20/2012 08:30 PM]

Certificate of Interest for the Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 08/20/2012 by email. [22091] This document has been rejected. See Doc No. [35] [Shannon Bloodworth] [Entered: 08/20/2012 08:42 PM]

Corrected Docketing Statement for the Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 08/20/2012 by email. [22092] This document has been rejected. See Doc No. [35] [Shannon Bloodworth] [Entered: 08/20/2012 08:43 PM]

Entry of appearance for Shannon M. Bloodworth as principal counsel for Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 08/21/2012 by email. [22259] [Shannon Bloodworth] [Entered: 08/21/2012 06:17 PM]

Entry of appearance for David L. Anstaett as of counsel for Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 08/21/2012 by email. [22260] [Shannon Bloodworth] [Entered: 08/21/2012 06:18 PM]

Entry of appearance for Brandon M. White as of counsel for Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 08/21/2012 by email. [22261] [Shannon Bloodworth] [Entered: 08/21/2012 06:18 PM]

Certificate of Interest for the Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 08/21/2012 by email. [22262] [Shannon Bloodworth] [Entered: 08/21/2012 06:26 PM]

Docketing Statement for the Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 08/21/2012 by email. [22263] [Shannon Bloodworth] [Entered: 08/21/2012 06:26 PM]

Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Service: 09/17/2012 by email. [25597] [Shannon Bloodworth] [Entered: 09/17/2012 04:44 PM]

Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Service: 09/17/2012 by email. [25617] [Deanne Maynard] [Entered: 09/17/2012 05:48 PM]

Entry of appearance for Adam A. Eltoukhy as of counsel for Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Service: 09/19/2012 by email. [25870] [Adam Eltoukhy] [Entered: 09/19/2012 12:18 PM]

Entry of appearance for Brian R. Matsui as of counsel for Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Service: 09/19/2012 by email. [25872] [Brian Matsui] [Entered: 09/19/2012 12:22 PM]

MOTION of Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc. to extend the time to 10/11/2012 to file the appellant/petitioner's principal brief. Response/Opposition due 10/09/2012. [Consent: unopposed]. Service: 09/24/2012 by email. [26619] [Deanne Maynard] [Entered: 09/24/2012 06:42 PM]

ORDER granting motion to extend time to file appellant/petitioner principal brief [46] filed by Appellants Sandoz, Inc. and Momenta Pharmaceuticals Inc. Brief due 10/11/2012.. Service: 09/25/2012 by clerk. [26722] [LAJ] [Entered: 09/25/2012 01:24 PM]

ORDER granting motion to extend time to file the principal brief [47] filed by Appellants Mylan Pharmaceuticals Inc., Mylan Inc. and Natco Pharma Ltd.. Service: 09/25/2012 by clerk. [26727] [LAJ] [Entered: 09/25/2012 01:30 PM]

CONFIDENTIAL BRIEF TENDERED from Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Title: Confidential Brief for Defendants-Appellants Sandoz Inc. and Momenta Pharmaceuticals Inc.. Service: 10/11/2012 by email. [29460] [Deanne Maynard] [Entered: 10/11/2012 06:51 PM]

BRIEF TENDERED from Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Title: Non-Confidential Brief for Defendants-Appellants Sandoz Inc. and Momenta Pharmaceuticals Inc.. Service: 10/11/2012 by email. [29463] [Deanne Maynard] [Entered: 10/11/2012 06:59 PM]

BRIEF TENDERED from Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Title: Non-Confidential Brief for Defendants-Appellants Sandoz Inc. and Momenta Pharmaceuticals Inc.. Service: 10/11/2012 by email. [29463]

BRIEF TENDERED from Appellants Momenta Pharmaceuticals Inc. and Sandoz, Inc.. Title: Non-Confidential Brief for Defendants-Appellants Sandoz Inc. and Momenta Pharmaceuticals Inc.. Service: 10/11/2012 by email. [29463]

BRIEF TENDERED from Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Title: Public Opening Brief of Defendants-Appellants Mylan Pharmaceuticals Inc., Mylan Inc. and Natco Pharma Ltd.. Service: 10/11/2012 by email. [29468] This brief has been rejected. See Doc. No. [55]

BRIEF TENDERED from Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Natco Pharma Ltd.. Title: Public Opening Brief of Defendants-Appellants Mylan Pharmaceuticals Inc., Mylan Inc. and Natco Pharma Ltd.. Service: 10/11/2012 by email. [29468] This brief has been rejected. See Doc. No. [55]

SANDOZ INTERNATIONAL GMBH

NOVARTIS AG

YEDA RESEARCH AND DEVELOPMENT CO., LTD.

TEVA NEUROSCIENCE, INC.

TEVA PHARMACEUTICAL INDUSTRIES, LTD.

TEVA PHARMACEUTICALS USA, INC.

NATCO PHARMA LIMITED

MYLAN PHARMACEUTICALS INC.

MYLAN INC.

MOMENTA PHARMACEUTICALS, INC.

SANDOZ INC.